Partners
Partners
Home Partners
Partners
Partners

Ascentage Pharma with its leading product pipeline, looking for technology transfer and joint development in China and around the world.

  • University of Michigan
  • Unity Biotechnology
  • Merck & Co., Inc.
  • University of Michigan

    U-M is one of the foremost research universities in the United States. The university has very high research activity and its comprehensive graduate program offers doctoral degrees in the humanities, social sciences, and STEM fields (Science, Technology, Engineering and Mathematics) as well as professional degrees in architecture, business, medicine, law, pharmacy, nursing, social work, public health, and dentistry.Ascentage is in a long-term research collaboration with U-M.


  • Unity Biotechnology

    UNITY Biotechnology is developing therapeutics that increase healthspan by preventing, halting or reversing diseases of aging. UNITY's initial focus is on creating senolytic medicines, which clear senescent cells that drive age-related afflictions such as osteoarthritis, atherosclerosis, eye diseases and kidney diseases. Backed by ARCH Venture Partners and Venrock, UNITY's world-class management team has experience building companies and developing medicines together and has collectively moved 91 therapeutic candidates into human clinical trials and developed 13 FDA-approved medicines. UNITY's mission is to build a future in which it doesn't hurt to be old — a future in which people stay healthy and mobile long into old age. More information is available at www.unitybiotechnology.com.

  • Merck & Co., Inc.

    Merck is a global healthcare company with a 125-year history .Its main business scope covers pharmaceuticals,vaccines,and animal health.The company posted revenue of  $39.8 billion in 2016.